Dr. Mallika Marshall answers a viewer question about whether it is dangerous to have a fatty liver. How many of these ...

Positive results from the MAESTRO-NASH OUTCOMES study could make resmetirom the first medication approved for patients with compensated NASH ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...

Discover why Sagimet Biosciences' Denifanstat is a top contender in treating MASH, with FDA designation and strong financials ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...

While the treatment options for this aggressive type ... Cavefish Provide New Insight Into Fatty Liver Disease Mar. 18, 2024 — Fatty liver, which can lead to liver damage and disease, can ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for cardiovascular disease – the leading cause of death worldwide.   University of Leeds ...

Researchers have developed a groundbreaking approach to tackling obesity by targeting fat absorption in the small intestine.

The prevalence rates of metabolic dysfunction–associated steatohepatitis (MASH) and metabolic dysfunction–associated ...

Molecules that produce hydrogen sulfide and specifically target mitochondria significantly reduced weight gain in mice.

Sagimet is a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional metabolic and fibrotic pathways in diseases ...

The majority of Americans consume alcohol to some extent. No matter what the time of year, a detox from alcohol is always a good way to see a slew of potential health benefits.